Literature DB >> 11240040

Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.

E Amyes1, J Curnow, Z Stark, L Corlett, I Sutton, A Vincent.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) occurs as a non-metastatic manifestation of cancer in a small proportion of patients with certain breast or gynaecological tumours, and is characterised by widespread Purkinje cell loss. Antibodies against a Purkinje cell cytoplasmic antigen, called Yo, that is expressed by the tumours, are present in the majority of these patients, but the pathogenic role of the antibodies is not clear. To characterise further the immune response in these cases, 13 anti-Yo positive sera were tested for IgG subclasses by immunohistochemistry and western blotting and, in four cases, PHA-stimulated cytokine secretion by peripheral blood lymphocytes was measured. Surprisingly, anti-Yo antibodies were entirely restricted to the IgG1 subclass, whereas antibodies against the small cell cancer-associated antigen, Hu, were found in all four IgG subclasses. There was a trend towards raised IgG1 levels in the total IgG of the anti-Yo positive patients and, in two, PHA-stimulated peripheral blood lymphocytes secreted raised levels of IFN-gamma. By contrast, in the other two cases tested, raised levels of IL-4 were secreted. Patients with PCD associated with anti-Yo antibodies appear to have strong immune responses that are polarised with respect to the IgG subclass and Th cytokine profiles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240040     DOI: 10.1016/s0165-5728(00)00445-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Neuroinflammation: Ways in Which the Immune System Affects the Brain.

Authors:  Richard M Ransohoff; Dorothy Schafer; Angela Vincent; Nathalie E Blachère; Amit Bar-Or
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 3.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

4.  Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features.

Authors:  Elise Peter; Le Duy Do; Salem Hannoun; Sergio Muñiz-Castrillo; Alberto Vogrig; Valentin Wucher; Anne-Laurie Pinto; Naura Chounlamountri; Walaa Zakaria; Veronique Rogemond; Geraldine Picard; Julien-Jacques Hedou; Aditya Ambati; Agusti Alentorn; Alexandra Traverse-Glehen; Mario Manto; Dimitri Psimaras; Emmanuel Mignot; Francois Cotton; Virginie Desestret; Jérôme Honnorat; Bastien Joubert
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-08-08

Review 5.  Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature.

Authors:  Michalis Liontos; Oraianthi Fiste; Danai Drakopoulou; Nikolaos Thomakos; Kalliroi Goula; Flora Zagouri; Maria Anagnostouli; Meletios-Athanasios Dimopoulos
Journal:  Gynecol Oncol Rep       Date:  2021-06-29

Review 6.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.